IGF2 Recombinant Monoclonal Antibody

說明書

中文名稱：

IGF2重組抗體
貨號：

CSB-RA011088A0HU
規格：

￥1320
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品描述：

CSB-RA011088A0HU IGF2重組單克隆抗體是經基因工程制備的高特異性科研試劑，靶向胰島素樣生長因子2（IGF2）。IGF2作為重要的細胞增殖調控因子，廣泛參與胚胎發育、組織再生及代謝平衡過程，其異常表達與多種生理病理機制相關。本產品經嚴格驗證適用于ELISA檢測，能特異性識別天然及重組形式IGF2蛋白，實驗數據顯示其具備優異的結合親和力和檢測靈敏度，批次間穩定性良好，適用于細胞培養上清、組織裂解液等樣本的定量分析。科研人員可將其用于探索IGF2在生長發育調控、代謝性疾病機制、腫瘤微環境研究等領域的生物學功能，支持體外蛋白互作分析、信號通路研究及疾病相關生物標志物檢測等基礎科研需求。該抗體通過重組表達技術生產，具有高純度、低交叉反應性特點，可為實驗數據可靠性提供保障。
Uniprot No.：

P01344
基因名：

IGF2
別名：

C11orf43 antibody; IGF 2 antibody; IGF II antibody; IGF-II antibody; IGF2 antibody; IGF2_HUMAN antibody; IGFII antibody; INSIGF antibody; insulin like growth factor 2 (somatomedin A) antibody; Insulin like Growth Factor 2 antibody; Insulin like growth factor II antibody; Insulin like growth factor II precursor antibody; Insulin like growth factor type 2 antibody; pp9974 antibody; Preptin antibody; putative insulin like growth factor II associated protein antibody; Somatomedin A antibody; Somatomedin-A antibody
反應種屬：

Human
免疫原：

A synthesized peptide derived from human IGF2
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
克隆類型：

Monoclonal
抗體亞型：

Rabbit IgG
純化方式：

Affinity-chromatography
克隆號：

1D6
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Rabbit IgG in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
產品提供形式：

Liquid
應用范圍：

ELISA
Protocols：

ELISA Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

The insulin-like growth factors possess growth-promoting activity. Major fetal growth hormone in mammals. Plays a key role in regulating fetoplacental development. IGF2 is influenced by placental lactogen. Also involved in tissue differentiation. In adults, involved in glucose metabolism in adipose tissue, skeletal muscle and liver (Probable). Acts as a ligand for integrin which is required for IGF2 signaling. Positively regulates myogenic transcription factor MYOD1 function by facilitating the recruitment of transcriptional coactivators, thereby controlling muscle terminal differentiation. Inhibits myoblast differentiation and modulates metabolism via increasing the mitochondrial respiration rate.; Preptin undergoes glucose-mediated co-secretion with insulin, and acts as physiological amplifier of glucose-mediated insulin secretion. Exhibits osteogenic properties by increasing osteoblast mitogenic activity through phosphoactivation of MAPK1 and MAPK3.
基因功能參考文獻：
1. serum preptin levels in women decrease after menopause and have a positive correlation with estradiol, femoral and total hip bone mineral density. PMID: 29134283
2. Analysis of patient serum samples showed that concurrent elevation of insulin like growth factor 2 (IGF2) and vascular endothelial growth factor (VEGF) levels may serve as a prognostic biomarker for oesophageal cancer. PMID: 28186102
3. Our results revealed that IGF-II promotes cell proliferation and EMT in HCC cells. PMID: 29970663
4. Serum preptin levels were significantly higher in women with polycystic ovary syndrome compared with controls. PMID: 29374985
5. infants with intrauterine growth restriction had higher serum levels of IGF2 if they had the A/G genotype at the ApaI restriction fragment length polymorphism and higher values of IGF2R if they had the A/A genotype PMID: 28460554
6. Upregulation of IGF-II expression is associated with ovarian cancer. PMID: 28829218
7. Data suggest that high IGF2 DMR methylation status would be a phenomenon that is observed with the progression of gastric cancer (GC) toward more aggressive features, supporting their potential utility as a biomarker in GC patients. PMID: 28871451
8. Data suggest that expression of CDKN1C and IGF2 is significantly up-regulated in placenta after assisted reproductive technology; DNA methylation was significantly down-regulated in DMR of CDKN1C and up-regulated in DMR of IGF2. (CDKN1C = cyclin-dependent kinase inhibitor-1C; IGF2 = insulin like growth factor 2; DMR = differential methylation regions) PMID: 29277274
9. The expression of miR-3941 was significantly down-regulated in acute pneumonia; IGF2 was confirmed as a direct target gene of miR-3941. PMID: 29328418
10. Our data reveal that vigilin is essential for maintenance of imprinting of IGF2 gene via functional interaction between KH1-7 domains of vigilin and zinc-finger domains of CTCF. PMID: 29157910
11. Low IGF-II serum levels were associated with Pancreatic Cancer. PMID: 28681154
12. Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells. PMID: 29758070
13. IGF2 rs680 polymorphism may have a role in endurance among Israeli athletes PMID: 29107196
14. low methylation of the Igf2 gene promoter region may promote the expression of Igf2 and miR4835p; this, in turn, induces the degradation of miR4835p target genes, and leads to the upregulation of oncogenes and the downregulation of tumor suppressors, which promotes the development of ESCC. PMID: 29207103
15. Results found IGF2 as a direct target gene of miR615 and restoring its expression reverses the inhibitory effects of miR615 in human esophageal squamous cell carcinoma cell motility. PMID: 29115555
16. A common indel variant in the 3'UTR of the IGF2 gene was associated with the risk of impaired renal function in an elderly population. PMID: 29889555
17. High molecular weight IGF-2 was associated with hypoglycemia in Recurrent Renal Cell Carcinoma. PMID: 24711554
18. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4 PMID: 29017567
19. HMGA1P7 mRNA sustains the H19 and Igf2 overexpression by acting as miRNA decoy. PMID: 27874091
20. Data suggest that blocking insulin-like growth factor 2 (IGF2) is a potential therapeutic mechanism for hepatocellular carcinoma (HCC). PMID: 29413895
21. IGF2 expression varies among mesenchymal stem cells derived from amniotic fluid, amnion, endometrium, and Wharton's jelly during culture period. PMID: 28629288
22. Results showed that IGF-2 was persistently expressed in oculomotor neurons in health and amyotrophic lateral sclerosis (ALS) and thus could play a role in oculomotor resistance in this disease. PMID: 27180807
23. Studies indicate that miR-663b is epigenetically repressed by long non-coding RNA HOTAIR and exerts its tumor-suppressive function via targeting insulin-like growth factor 2 (IGF2) in pancreatic cancer. PMID: 27895308
24. IGF-II-mediated loss of E-cadherin is central in developing hepatomegaly in mice and abnormal cell growth in the hepatoma cell line PMID: 27486970
25. Aberrant IGF2 imprinting may be an intrinsic epigenetic control mechanism that enhances stemness, self-renewal and chemo/radiotherapy resistance in cancer stem cells. PMID: 27275535
26. DNMT1-mediated transcriptional upregulation of IGF2 is a novel mechanism of resistance to HDIs, highlighting the role of epigenetic deregulation of IGF2 in HDI resistance and the potential value of the H19/IGF2 ICR hypermethylation and DNMT1 expression as predictive biomarkers in HDI-based anticancer therapies. PMID: 27582487
27. Human H19/Igf2 imprinting control regions can functionally replace mouse H19/Igf2 imprinting control regions on the maternal allele. PMID: 27621468
28. IGF2 may exert its oncofunction, at least partly, through its parasitic miR-483 which suppressed DLC-1 in colorectal cancer cells. PMID: 27366946
29. We report here the first deletions of ICR1 associated with hypomethylation of the IGF2/H19 domain leading to SRS. PMID: 27701793
30. Methylation patterns of IGF2 regulatory regions can discriminate adrenocortical carcinomas from adrenocortical adenomas with high diagnostic accuracy. PMID: 27535174
31. IGF-II siRNA inactivates the FAK/PI3K/Akt signaling pathway, and further reduces cell proliferation, N-ras and C-myc levels in SMMC-7721 cells. PMID: 27768959
32. Study shows impact of folic acid intake during pregnancy on genomic imprinting of IGF2/H19 and 1-carbon metabolism PMID: 28778973
33. produced by pericentral hepatocytes to promote hepatocyte proliferation and repair tissue damage in the setting of chronic liver injury PMID: 28653763
34. These findings suggest that reducing IGF2 isoform 2 expression in relevant tissues has potential as a new therapeutic strategy for type 2 diabetes, even beyond the Latin American population, with no major adverse effects on health or reproduction. PMID: 28838971
35. this is the first report of IGF2/H19 domain triplication associated with BWS or SRS and the second report of a maternal amplification of this region in a patient with clinical features of SRS. This study further supports the hypotheses that the amplification of the H19/IGF2 region on the maternal chromosome can lead to an SRS phenotype. PMID: 27612309
36. stroma-induced IGF2 promotes colon cancer progression in a paracrine and autocrine manner and propose IGF2 as potential target for tumor stroma cotargeting strategies. PMID: 28534511
37. We identified vascular INSR expression as a potential biomarker for progression in bladder cancer. The data suggest that IGF-2/INSR mediated paracrine crosstalk between bladder cancer cells and endothelial cells is functionally involved in tumour angiogenesis and may thus represent a new therapeutic target. PMID: 28295307
38. Methylation of IGF2AS is altered 20 years after preterm birth at VLBW. Altered methylation may be a mechanism of later increased disease risk but more data are needed to indicate causality PMID: 23840686
39. Prenatal 'unhealthy diet' was positively associated with IGF2 methylation at birth, and with ADHD and conduct disorder. PMID: 27535767
40. High IGF2 expression is associated with breast cancer. PMID: 27546618
41. IGF2 and insulin receptor A are important for uterine leiomyoma stem cell proliferation and may represent paracrine signaling between leiomyoma cell types. PMID: 28324020
42. IGF2 overexpression is associated with cancer. PMID: 27869826
43. Long non-coding RNA 91H is overexpressed in breast cancer and 91H-induced epigenetic modifications on H19/IGF2 locus suggest that 91H may play essential role in breast cancer development. PMID: 27780718
44. our results suggest that IGF2 via AKT1 contributes to non-canonical wnt signaling. PMID: 26984550
45. Elevated insulin-like growth factor 2 expression is associated with Beckwith-Wiedemann syndrome. PMID: 27650505
46. Here we present IGF2, which is re-expressed through epigenetic mechanisms, as the first actionable validated epi-driver in hepatocellular carcinoma. PMID: 27614046
47. results demonstrate that the H19-Igf2 axis is negatively regulated by CTCF-PHB1 cooperation and that H19 is involved in modulating the growth-suppressive effect of PHB1 in the liver. PMID: 27687727
48. Compared with obstructive azoospermia (OA) as normal control, our results suggest that miR-210 was significantly up-regulated in testis of patients with non-obstructive azoospermia (P<0.05), and IGF2 was down-regulated, but without a significant difference. PMID: 27535712
49. The identification of the INS-IGF2 read-through transcript specifically in tumor tissue but not in normal pancreatic tissue suggests that high expression of INS-IGF2 could be neoplasiaspecific PMID: 27667266
50. DNA methylation of imprinted loci of IGF2 is not affected in Parkinson's disease patients. PMID: 28081695
顯示更多

收起更多
相關疾病：

Silver-Russell syndrome (SRS); Growth restriction, severe, with distinctive facies (GRDF)
亞細胞定位：

Secreted.
蛋白家族：

Insulin family
組織特異性：

Expressed in heart, placenta, lung, liver, muscle, kidney, tongue, limb, eye and pancreas.
數據庫鏈接：

HGNC: 5466

OMIM: 147470

KEGG: hsa:3481

STRING: 9606.ENSP00000391826

UniGene: Hs.272259

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human